We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clinical Trial for Lung Cancer Treatment Brings Good News for Eli Lilly
Clinical Trial for Lung Cancer Treatment Brings Good News for Eli Lilly
August 13, 2013
A clinical trial for Eli Lilly’s necitumumab showed the lung cancer drug increases patient survival, skyrocketing past low expectations from Wall Street analysts skeptical of the drug after safety concerns stopped a previous trial.